Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)

Alexander I. Ngwube, MD, Niketa C. Shah, MD, David Jacobsohn, MD, Edward Dela Ziga, MD, Shalini Shenoy, MD

Blood (2019) 134 (Supplement_1): 370.

https://doi.org/10.1182/blood-2019-126405

Published: 2019

Journal Articles

Preemptive Therapy Based on the Load and Time of EBV-Emia for Preventing EBV Related PTLD after Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study

Can Liu, Ren Lin, Yu Wang, Fen Huang, MD, Zhiping Fan, MD, Shen Zhang, Yajing Xu, MD PhD, Ting Yang, Li Xuan, MD, Na Xu, Jieyu Ye, MD PhD, Jing Sun, Xiaojun Huang, MD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 5693.

https://doi.org/10.1182/blood-2019-132106

Published: 2019

Journal Articles

T- and B-Cell Neogenesis Recovers Efficiently in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Followed By Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (BPX-501 cells)

Marialuigia Catanoso, MD, Emmanuel Clave, PhD, Corinne Douay, Mattia Algeri, MD, Isabelle Fournier, Valentina Bertaina, Itaua Leston Araujo, MSc, Francesca Del Bufalo, MD, Federica Galaverna, MD, Cecilia Surace, PhD, Alice Bertaina, MD PhD, Pietro Merli, MD, Aaron Foster, PhD, Antoine Toubert, MD PhD, Franco Locatelli

Blood (2018) 132 (Supplement 1): 4560.

https://doi.org/10.1182/blood-2018-99-116536

Published: 2018

Journal Articles

Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Marthe C.J. Roex, MD, Peter van Balen, MD, Lothar Germeroth, PhD, Lois Hageman, Esther van Egmond, Sabrina A.J. Veld, Conny Hoogstraten, Ellis van Liempt, PhD, Jaap J. Zwaginga, MD PhD, Liesbeth C. de Wreede, PhD, Hermann Einsele, MD PhD, Hendrik Veelken, MD PhD, Constantijn J.M. Halkes, MD, Inge Jedema, PhD, J.H. Frederik Falkenburg, MD PhD

Blood (2018) 132 (Supplement 1): 119.

https://doi.org/10.1182/blood-2018-99-111749

Published: 2018

Journal Articles

Adoptive Therapy with EBV-Specific T Cells for Treatment of CNS EBV Post-Transplant Lymphoproliferative Disease Arising after Hematopoietic Stem Cell Transplant or Solid Organ Transplant

Susan Prockop, MD, Stephanie Suser, Ekaterina Doubrovina, MD PhD, Hugo R. Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, James W. Young, MD, Victoria Szenes, PNP, Alison Slocum, MA, Karim Baroudy, MS, Richard J. O'Reilly, MD

Blood (2018) 132 (Supplement 1): 4590.

https://doi.org/10.1182/blood-2018-99-120133

Published: 2018

Journal Articles

EBV-Related Post-Transplant Lymphoproliferative Disease in Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience and Considerations Regarding CNS Involvement

Anna Vardi, MD PhD, Ioanna Sakellari, Andriana Lazaridou, Apostolia Papalexandri, Ioannis Batsis, Despina Mallouri, Anastasia Marvaki, Tasoula Touloumenidou, Evangelia Yannaki, Michalis Iskas, Varnavas Constantinou, Eleni Gavriilaki, MD, Styliani Papaemmanouil, Achilles Anagnostopoulos

Blood (2018) 132 (Supplement 1): 5706.

https://doi.org/10.1182/blood-2018-99-118008

Published: 2018

Journal Articles

Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against AdV, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant

Blood (2017) 130 (Supplement 1): 4484.

https://doi.org/10.1182/blood.V130.Suppl_1.4484.4484

Published: 2017

Journal Articles

The Utility of Repeated Endoscopy in Patients with Gastrointestinal Graft-Versus-Host Disease: Single Center Retrospective Analysis

Ehsan Shabbir, MD, Sarah Mott, MS, Lindsay Dozeman, Umar Farooq, MD, Margarida Silverman, MD

Blood (2017) 130 (Supplement 1): 5487.

https://doi.org/10.1182/blood.V130.Suppl_1.5487.5487

Published: 2017

Journal Articles

Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study

Blood (2017) 130 (Supplement 1): 3318.

https://doi.org/10.1182/blood.V130.Suppl_1.3318.3318

Published: 2017

Journal Articles

Prevention of Viral Infections after T Cell Depleted Allogeneic Stem Cell Transplantation By Infusion of Multi-Antigen Specific T Cell Products

Marthe C.J. Roex, MD, Peter Van Balen, MD, Lois Hageman, Esther Van Egmond, Sabrina A.J. Veld, Conny Hoogstraten, Ellis van Liempt, PhD, Lothar Germeroth, PhD, Hermann Einsele, MD, Constantijn J.M. Halkes, MD PhD, Inge Jedema, PhD, J.H. Frederik Falkenburg, MD PhD

Blood (2016) 128 (22): 1228.

https://doi.org/10.1182/blood.V128.22.1228.1228

Published: 2016

Journal Articles

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Ifigeneia Tzannou, MD, Anastasia Papadopoulou, PhD, Ayumi Watanabe, Manik Kuvalekar, Adrian P. Gee, PhD, Swati Naik, MD, Caridad Martinez, MD, Kathryn S. Leung, Ghadir S. Sasa, MD, Robert A. Krance, MD, George Carrum, MD, Carlos A. Ramos, MD, Bambi Grilley, Malcolm K. Brenner, MD PhD, Cliona M. Rooney, PhD, Helen E Heslop, MD DSc (Hon), Ann M. Leen, PhD, Bilal Omer, MD

Blood (2016) 128 (22): 501.

https://doi.org/10.1182/blood.V128.22.501.501

Published: 2016

Journal Articles

Preemptive Therapy with Rituximab for Epstein-Barr Virus Reactivation in Children after T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Low-Dose Anti-Thymocyte Globulin

Shogo Kobayashi, Hideki Sano, Kazuhiro Mochizuki, Mitsuko Akaihata, Yoshihiro Ohara, Nobuhisa Takahashi, Hitoshi Ohto, Atsushi Kikuta

Blood (2016) 128 (22): 5760.

https://doi.org/10.1182/blood.V128.22.5760.5760

Published: 2016

Journal Articles

Infection Burden of Double Stranded DNA (dsDNA) Viruses after CD34 + Selected, T-Cell Depleted (TCD) Hematopoietic Cell Transplantation (HCT) for Myeloid Malignancies at Memorial Sloan Kettering Cancer Center (MSK)

Yao-Ting Hayden Huang, PhD MPH, Seong Jin Kim, MPH, Yeon Joo Lee, MD MPH, Daniel Burack, BS, Paige Nichols, BA, Molly Maloy, MS, Roni Tamari, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Hugo R. Castro-Malaspina, MD, Esperanza B Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Genovefa A Papanicolaou, MD

Blood (2015) 126 (23): 4320.

https://doi.org/10.1182/blood.V126.23.4320.4320

Published: 2015

Journal Articles

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Bilal Omer, MD, Anastasia Papadopoulou, PhD, Nikita Koottiyaniyil, Adrian P. Gee, PhD, Swati Naik, MD, Caridad Marinez, MD, Leung Kathryn, MD, Ghadir S. Sasa, MD, Robert A. Krance, MD, Bambi Grilley, RPh, Malcolm K. Brenner, MD PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD, Ann M. Leen, PhD, Ifigeneia Tzannou, MD

Blood (2015) 126 (23): 622.

https://doi.org/10.1182/blood.V126.23.622.622

Published: 2015

Journal Articles

Low Dose ATG-Fresenius Might be Effective in the Prophylaxis of Severe Graft Versus Host Disease with Low Non-Relapse Mortality

Irati Ormazabal Velez, Maria Aranzazu Bermudez, MD, Andres Insunza, Lucrecia Yañez, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2015) 126 (23): 5468.

https://doi.org/10.1182/blood.V126.23.5468.5468

Published: 2015

Journal Articles

EBV Related Lymphoproliferative Disorders Post Allogeneic Bone Marrow Transplantation for Haematological Malignancies

A. Paisiou, MD, C. M. Vadikolia, MD PhD, K. Stefanaki, MD, E. Goussetis, MD PhD, I. Peristeri, MD, K. Zisaki, MD, G. Avgerinou, MD, G. Vessalas, MD, V. Kitra, MD, S. Grafakos, MD

Blood (2015) 126 (23): 5480.

https://doi.org/10.1182/blood.V126.23.5480.5480

Published: 2015

Journal Articles

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Ifigeneia Tzannou, MD, Bilal Omer, MD, Anastasia Papadopoulou, PhD, Ulrike Gerdemann, MD, Colton Smith, PhD, Adrian P. Gee, PhD, Bambi J Grilley, Malcolm K. Brenner, MB, PhD FRCP, FRCPath, Catherine M. Bollard, MD, Ann M. Leen, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD

Blood (2015) 126 (23): 1926.

https://doi.org/10.1182/blood.V126.23.1926.1926

Published: 2015

Journal Articles

Weekly Low-Dose Rituximab As the Preemptive Management of Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Novel Strategy?

Feng Chen, Wu Depei, MD, Tao Tao, Wei Gong, Chunmei Ye, XiaoWen Tang, MD, Yue Han, MD, Huiying Qiu

Blood (2015) 126 (23): 3158.

https://doi.org/10.1182/blood.V126.23.3158.3158

Published: 2015

Journal Articles

CD34-Selected, T Cell-Depleted Alternative Donor Stem Cell Transplantation For Children

Andrew Gilman, Michael Eckrich, MD, Stacy Epstein, PharmD, Carrie Barnhart, RN, Javier Oesterheld, MD, Darci Grochowski, PA, Tracy Fukes, RN, Maria Lacaria, RN, Mark Cannon, BA

Blood (2013) 122 (21): 2064.

https://doi.org/10.1182/blood.V122.21.2064.2064

Published: 2013

Journal Articles

Rituximab-Based Treatments Followed By Adoptive Cellular Therapies For EBV-Associated Post-Transplant Lymphoproliferative Disease In Recipients Of Allogeneic Hematopoietic Stem Cell Transplantation

Xinmiao Jiang, Lanping Xu, Yu Zhang, Fen Huang, MD, Daihong Liu, Jing Sun, MD, Chaoyang Song, Xinquan Liang, Zhiping Fang, Hongsheng Zhou, Min Dai, Can Liu, Ph.D, Qianli Jiang, Na Xu, Li Xuan, Meiqing Wu, Xiaojun Huang, Qifa Liu, M.D.

Blood (2013) 122 (21): 4637.

https://doi.org/10.1182/blood.V122.21.4637.4637

Published: 2013

NARROW

Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)

Preemptive Therapy Based on the Load and Time of EBV-Emia for Preventing EBV Related PTLD after Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study

T- and B-Cell Neogenesis Recovers Efficiently in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Followed By Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (BPX-501 cells)

Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Adoptive Therapy with EBV-Specific T Cells for Treatment of CNS EBV Post-Transplant Lymphoproliferative Disease Arising after Hematopoietic Stem Cell Transplant or Solid Organ Transplant

EBV-Related Post-Transplant Lymphoproliferative Disease in Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience and Considerations Regarding CNS Involvement

Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against AdV, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant

The Utility of Repeated Endoscopy in Patients with Gastrointestinal Graft-Versus-Host Disease: Single Center Retrospective Analysis

Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study

Prevention of Viral Infections after T Cell Depleted Allogeneic Stem Cell Transplantation By Infusion of Multi-Antigen Specific T Cell Products

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Preemptive Therapy with Rituximab for Epstein-Barr Virus Reactivation in Children after T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Low-Dose Anti-Thymocyte Globulin

Infection Burden of Double Stranded DNA (dsDNA) Viruses after CD34 + Selected, T-Cell Depleted (TCD) Hematopoietic Cell Transplantation (HCT) for Myeloid Malignancies at Memorial Sloan Kettering Cancer Center (MSK)

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Low Dose ATG-Fresenius Might be Effective in the Prophylaxis of Severe Graft Versus Host Disease with Low Non-Relapse Mortality

EBV Related Lymphoproliferative Disorders Post Allogeneic Bone Marrow Transplantation for Haematological Malignancies

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Weekly Low-Dose Rituximab As the Preemptive Management of Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Novel Strategy?

CD34-Selected, T Cell-Depleted Alternative Donor Stem Cell Transplantation For Children

Rituximab-Based Treatments Followed By Adoptive Cellular Therapies For EBV-Associated Post-Transplant Lymphoproliferative Disease In Recipients Of Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only